Title: ANTIBIOTICS
1 ANTIBIOTICS
2Monobactams
Aetreonam Action spectrum - Gram (-) bacteria,
including Escherichia colli, Clebsiellas,
Proteum, Haemophilus influenzae (activity is
equal to the activity of cephaloporins of third
generation) Ways of introduction oral (20 are
being absorbed), intramuscular,
intravenous Clinical uses sepsis, infection of
urinary tracts, soft tissues, meningitis and
others (often combined with aminoglycosides ,
clindamycin, metronidazole, vankomycin).
3Carbapenems (tienamytsin) Tienam (imipenem
cylastatin) Meropenem
The widest spectrum of antibacterial action -
most of aerobe and anaerobe Gram() and Gran (-)
bacteria, including those which produse
beta-lactamase
4Classificaion of macrolides
- ?. Natural substances erythromycin,
oleandomycin,spiramycin, jozamycin, midecamycin. - ??. Half-synthetic substances rozythromycin,
clarithromycin, flurythromycin, dyrythromycin,
miokamycin, rokitamycin. - III. Azalides (neutrogen atom is introduced in
lacton ring) azithromycin.
5Erythromycin
6Macropen (midecamycin)
7Sumamed (azithromycin)
8Action spectrum of maclrolides and azalides
- staphylo-, strepto-, hono-, anaerobe cocci,
enterobacteria - H.influenzae (clarythromycin, azithromycin)
- intracellular situated microorganisms (stamps of
Helicobacter, Chlamydia, Legionell?, M.
pneumoniae, U. urealyticum etc.)
9Pharmacokinetics of macrolides
- Quiclkly and fully distributed through the
tissues (do not pass through HEB) - Correlation tissues/blood
- Erythromycin (5-10) 1
- Azithromycin (100-500) 1
- Their concentration in phagocyting cells prevails
concentration in blood pasma in 12-20 times, they
get accumulated in source of inflammation -
macrolides paradoxis
10Indications for usage of macrolides and azalides
- LOR- infections, infections of upper respiratory
tracts, hynecological infection, skin and soft
tissues infections ulcer disease dyphteria
whooping-cough honorrhea syphilis typhoid
fever (azithromycin). - Drugs of choice for mycoplasma, chlamidial,
legionela pneumonia
11Side affects of microlides
- Dispeptic disorders, disbacteriosis,
superinfection - Cholestasis, cholestatic jaundice (erythromycin)
- Depression of liver microsome enzyme activity
(erythromycin, oleandomycin can not be combined
with theophylline, ergot alkaloids,
carbamazepine) - Development of resistance in process of
treatment
12Linkosamides
- Linkomycin Clindamycin
- Action spectrum Gram positive aerobe cocci,
grampositive and gramnegatvie anaerobes - Penetrate all the tissues (dont pass through
HEB) including intracellurally - Usage usually in heavy infections, caused by
anaerobe microorganisms - Complicated side affects
13Linkomycini hydrochloridum
14Dalacyn C (clindamycini hydrochloridum)
15Tetracyclines
- 1. Natural - biosynthetic chlortetracycline,
oxytetracycline, tetracycline, dimethylchlortetrac
ycline. - 2. Semisynthetic - doxycycline (vibramycin),
metacycline (rondomycin), minocycline.
16Tetracycline
17Doxycycline
18Vibramycin (doxycycline)
19Shemes of tetracyclines administration
- Tetracycline - 0,25-0,5 g 4 times per 24 hours
- Methacycline 0,3-0,6 g 2 times per 24 hours
- Doxycycline 0,2 g (first day), 0,1g (next
days) 1 time per 24 hours
20Pharmacokinetics of tetracyclines when combined
with other drugs
Drugs Results of combined administration
Antacides (Ca, Mg etc.) Iron preparations Rifampicin Decrease of absorbtion Decrease of absorbtion Increase of elimination
21Side affects of tetracyclines
- Dispeptic disorders, stomatitis, glositis,
esophagitis, pruritus etc). - Disbacteriosis and superinfection with Candida
fungi, proteus, pseudomonadas or staphylococci. - Photodermatosis.
- Liver toxicity.
- Absorbtion by bones and teeth of a featus or a
child hipoplasia of dental enamel, disorder of
teeth formation, tendency for caries. - Antianabolic action, damage of kidneys (when
using tetracyclines with long termed storage,
using big doses). - Tetracyclines are forbidden for children under
the age of 8, during pregnancy, liver diseases,
kidney insufficiency, miastenia).
22Photosensitization - tetracyclines
23tetracyclines
24AMINOGLYCOSIDES
- ? generation streptomycin, neomycin, monomycin,
kanamycin. - ?? generation gentamycin (garamycin),
tobramycin, syzomycin. - ??? generation netilmicin (netromycin),
amikacin.
25Gentamycin
26Action spectrum of aminoglycosides
- wide
- gram-negative bacteria (escherichia colli,
salmonella, klebsiella, especially K. ?neumoniae,
proteus iersinia, brucella, campilobacteria,
helicobacters,serratsia, shigella etc.).
- some gram-positive microorganisms, including
staphylococci which are resistant to other
antibiotics.
27Indications for usage of aminoglycosides
- - at the beginning stage of infectious processes
of unknown ethiology and severe complexity
(combined with beta-lactamase) - - considerable purulent-inflammatory component
of heavy infections (peritonitis, sepsis,
mediastinitis, abscesses and flegmones of soft
tissues) - - acute attack of chronical purulent-inflammatory
diseases, including secondary immune
defficiency - - early stage of development of secondary
bacterial meningitis - - bacterial endocarditis
- - infections of urinary tracts
- - for prophilaxis of postoperative pustural
complications (combined with beta-lactamase
antibiotics, metronidazole or other antianaerobe
drugs) - - skin infections and subcutaneous fat tissue
infections, burns.
28- Concentration of aminoglycosides in blood should
not overcome - Amikacin, kanamycin 35-40 mkg/ml
- Gentamicin, tobramycin 10-12 mkg/ml
29Complications in administration of aminoglycosides
- Ototoxicity
- Nephrotoxicity
- Neurotoxicity
- According to extent of toxicity
- netilmicin lt gentamicin lttobramycin lt amikacin lt
neomycin lt streptomycin lt monomycin lt kanamycin - Leuko-, thrombocytopenia, hemmorhages, hemolisis
- Allergic reactions
30Chloramphenicol levomycetin
- Indications meningitis, typhoid fever,
paratyphoid fever, brucellosis, tularemia - Side affects
- Hypochrome and aplastic anemia
- Granulocytopenia, thrombocytopenia
- Grey syndrome of a featus
- Disbacteriosis and superinfection
31Glycopeptide antibiotics
- Vankomycin Teikoplanin
- Active towards ?RS ? MRCNS